PL4399216T3 - Immunomodulujące azalidy - Google Patents

Immunomodulujące azalidy

Info

Publication number
PL4399216T3
PL4399216T3 PL22777846.1T PL22777846T PL4399216T3 PL 4399216 T3 PL4399216 T3 PL 4399216T3 PL 22777846 T PL22777846 T PL 22777846T PL 4399216 T3 PL4399216 T3 PL 4399216T3
Authority
PL
Poland
Prior art keywords
azalides
immunomodulating
immunomodulating azalides
Prior art date
Application number
PL22777846.1T
Other languages
English (en)
Inventor
Mark R. Cox
Richard A. EWIN
Tomasz RESPONDEK
Imelda HOT
Todd M. Maddux
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of PL4399216T3 publication Critical patent/PL4399216T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL22777846.1T 2021-09-07 2022-09-02 Immunomodulujące azalidy PL4399216T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163241126P 2021-09-07 2021-09-07
PCT/US2022/042421 WO2023038852A1 (en) 2021-09-07 2022-09-02 Immunomodulating azalides

Publications (1)

Publication Number Publication Date
PL4399216T3 true PL4399216T3 (pl) 2026-04-20

Family

ID=83457385

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22777846.1T PL4399216T3 (pl) 2021-09-07 2022-09-02 Immunomodulujące azalidy

Country Status (15)

Country Link
US (2) US12378233B2 (pl)
EP (1) EP4399216B1 (pl)
JP (1) JP7770547B2 (pl)
KR (1) KR20240056746A (pl)
CN (1) CN118139870A (pl)
AU (1) AU2022343476B2 (pl)
CA (1) CA3231535A1 (pl)
CL (1) CL2024000657A1 (pl)
CO (1) CO2024002712A2 (pl)
DK (1) DK4399216T3 (pl)
MX (1) MX2024002892A (pl)
PL (1) PL4399216T3 (pl)
PT (1) PT4399216T (pl)
WO (1) WO2023038852A1 (pl)
ZA (1) ZA202401768B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202412461D0 (en) * 2024-08-23 2024-10-09 Epiendo Pharmaceuticals Ehf Medial use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5985844A (en) 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
MXPA02007305A (es) 2000-01-27 2002-11-29 Pfizer Prod Inc Composiciones antiboticas de azalida.
CA2407448A1 (en) 2000-04-27 2001-11-01 Pfizer Products Inc. The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
ATE321770T1 (de) * 2000-08-17 2006-04-15 Kitasato Inst Pseudoerythromycin-derivate
ITMI20022292A1 (it) 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
ITMI20040124A1 (it) * 2004-01-29 2004-04-29 Zambon Spa Macrolidi ad attivita' antiinfiammatoria
CA2733706A1 (en) * 2007-08-10 2009-02-19 Y's Therapeutics Co., Ltd. Modulation of immune responses by administration of roxithromycin or its derivative
US20130045939A1 (en) * 2010-03-19 2013-02-21 Catabasis Pharmaceuticals, Inc. Fatty acid macrolide derivatives and their uses
AU2014252462A1 (en) 2013-04-10 2015-10-01 Probiotic Pharmaceuticals Aps Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect
GB201520419D0 (en) * 2015-11-19 2016-01-06 Epi Endo Pharmaceuticals Ehf Compounds
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds
KR20220156570A (ko) 2020-03-12 2022-11-25 조에티스 서비시즈 엘엘씨 면역조절성 유레아 아잘라이드

Also Published As

Publication number Publication date
EP4399216A1 (en) 2024-07-17
JP2024535760A (ja) 2024-10-02
CN118139870A (zh) 2024-06-04
AU2022343476A1 (en) 2024-03-21
US12378233B2 (en) 2025-08-05
CL2024000657A1 (es) 2024-07-05
KR20240056746A (ko) 2024-04-30
US20230129040A1 (en) 2023-04-27
CA3231535A1 (en) 2023-03-16
US20250236616A1 (en) 2025-07-24
DK4399216T3 (da) 2026-03-16
PT4399216T (pt) 2026-03-24
AU2022343476B2 (en) 2025-02-20
MX2024002892A (es) 2024-04-05
WO2023038852A1 (en) 2023-03-16
JP7770547B2 (ja) 2025-11-14
ZA202401768B (en) 2025-08-27
EP4399216B1 (en) 2025-12-31
CO2024002712A2 (es) 2024-03-27

Similar Documents

Publication Publication Date Title
CA202905S (en) Half-boot
CA208524S (en) Soundbar
CA196956S (en) Onesie
CA207519S (en) Smartglasses
DK3957371T3 (en) Havaricontainer
CA207517S (en) Smartglasses
CA207516S (en) Smartglasses
DK4181849T3 (en) Akkvisition-distribution-lag
CA204810S (en) Playard
DK4121781T3 (en) Fiberoptisk accelerationssensor
ZA202209530B (en) Immunomodulating urea azalides
DK4244933T3 (en) Antennesystem
CA199411S (en) Handshower
DK4036424T3 (en) Profilsystem
CA200872S (en) Nighstand
ZA202401768B (en) Immunomodulating azalides
CA206631S (en) Mandoline
CA204263S (en) Brushguard
GB202104749D0 (en) Early entry
CA198107S (en) Protractor-ruler
CA212416S (en) Aéronef
DK4313500T3 (en) Industrirobot
CA212654S (en) Velomobile
DK4304956T3 (en) Transportsystem
DK4197885T3 (en) Hydraulisk styresystem